Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local dexamethasone injection for ocular myasthenia gravis
ChiCTR2000038863Phase 4Completed
- Sponsor
- Wuhan Aier Eye Hospital
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexamethasone in myasthenia gravis (MG), sponsored by Wuhan Aier Eye Hospital. Primary endpoints: Squint degree, Palpebral margin activity and 1 more. Started Aug 2016; status: completed.
02
Drugs
dexamethasone
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on ChiCTR2000038863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038863.